GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent Health Corp (OTCPK:EMGE) » Definitions » Short-Term Debt

Switch to:

Emergent Health (Emergent Health) Short-Term Debt : $0.00 Mil (As of . 20)

View and export this data going back to 2007. Start your Free Trial

What is Emergent Health Short-Term Debt?

Emergent Health's Short-Term Debt for the quarter that ended in . 20 was $0.00 Mil.

Emergent Health Short-Term Debt Historical Data

The historical data trend for Emergent Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent Health Short-Term Debt Chart

Emergent Health Annual Data

Trend

Short-Term Debt

Emergent Health Quarterly Data

Short-Term Debt

Emergent Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Emergent Health Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Emergent Health's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Emergent Health (Emergent Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent Health Corp (OTCPK:EMGE) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

519 8th Avenue, 25th Floor, New York, NY, USA, 10018

Website

https://www.emergenthealthcompany.com

Emergent Health Corp manufactures and sells vitamin products to retail customers across the United States of America.

Emergent Health (Emergent Health) Headlines

From GuruFocus

Emergent's Pending Acquisition "Evolutionary Biologics" Engages "Aesthetics By Design" to Market, Sell and Distribute Regenerative Medicine Products Produced by Evolutionary Biologics with the Initial Focus Being Exo Elixir(TM)

By ACCESSWIRE ACCESSWIRE • 07-26-2022

Former L'Or�al President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Revenues of $185,471 for the Quarter Ended September 30, 2022, as Compared to $ 28,082 for the Quarter Ended September 30, 2021, an increase of over 600%

By ACCESSWIRE ACCESSWIRE • 11-21-2022

Emergent Acquires Regen Biowellness, Inc.

By ACCESSWIRE ACCESSWIRE • 08-02-2022

Emergent Projects $3.5 Million in Revenues With Acquisition of Nanosthetic Corp. Fueling Evolutionary Biologics

By ACCESSWIRE ACCESSWIRE • 02-07-2023

Emergent Health Announces Revenue Forecast of $16 Million & Introduces 'MAXIMUS Men's Health'

By ACCESSWIRE ACCESSWIRE • 02-28-2023

Emergent Subsidiary "PharmaZu" Launches E-Commerce Online Platform Entering the Estimated $8.5 Billion-Dollar Online Pet Medicine Industry

By ACCESSWIRE ACCESSWIRE • 01-03-2023

Emergent Acquires Evolutionary Biologics, Former L'Or�al President Jim Morrison to Become Full Time CEO of Emergent Effective August 15, 2022

By ACCESSWIRE ACCESSWIRE • 08-09-2022

Emergent and Proposed Acquisition Partner Regen Biowellness to Re-Launch FDA Registered Patented Immune Booster ImmunaZin(TM) To Significantly Increase Revenues

By ACCESSWIRE ACCESSWIRE • 07-12-2022

Emergent Closing in on Acquisition of Regen Biowellness Regens Bankruptcy Motion to Dismiss Approved Former L'Or�al President Jim Morrison Set to Join Emergents Board of Directors

By ACCESSWIRE ACCESSWIRE • 07-21-2022

The Former President of Loreal and Emergents Current Chairman of the Board and Soon to be Chief Executive Officer Jim Morrison to Appear on the Digital Stock & Investment News Network Rich TV Live

By ACCESSWIRE ACCESSWIRE • 08-10-2022

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.